The presence of a patent foramen ovale (PFO) is implicated in the pathogenesis of a number
of medical conditions; however, the subject remains controversial and no official statements …

Embolism from the heart or the thoracic aorta often leads to clinically significant morbidity
and mortality due to transient ischemic attack, stroke or occlusion of peripheral arteries …

The aim of this updated guideline is to provide comprehensive and timely evidence-based
recommendations on the prevention of future stroke among survivors of ischemic stroke or …

Objective: We aimed to create an index to stratify cryptogenic stroke (CS) patients with
patent foramen ovale (PFO) by their likelihood that the stroke was related to their PFO …

The aim of this updated statement is to provide comprehensive and timely evidence-based
recommendations on the prevention of ischemic stroke among survivors of ischemic stroke …

В книге обобщены последние достижения по проблеме ишемического инсульта-одной
из основных причин смертности и ранней инвалидизации больных. Авторы описывают …

Introduction: Percutaneous closure of patent foramen ovale (PFO) in selected patients with
cryptogenic cerebrovascular ischemic events (CEs) decreases the risk of recurrent stroke; …

Patent foramen ovale (PFO) is the most common congenital heart abnormality of fetal origin
and is present in approximately∼ 25% of the worldwide adult population. PFO is the …

Background In patients with patent foramen ovale (PFO)–associated stroke, the presence of
large shunt or atrial septal aneurysm (ASA) has been suggested to convey a high risk of …

Patent foramen ovale (PFO) is a normal fetal communication between the right and left atria
that persists after birth. PFO is a common finding that occurs in 20–34% of the population …